Dyna Drugs
✅ Low Risk
FEI: 3003388279 • Manila • PHILIPPINES
FEI Number
3003388279
Location
Manila
Country
PHILIPPINESAddress
608 Sta. Elena St. San Nicolas, , Manila, , Philippines
Low Risk
FDA Import Risk Assessment
This firm has a minimal history of FDA import refusals with low-severity violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 8/6/2010 | 60LBY99ANALGESIC, N.E.C. | 118NOT LISTED | Chicago District Office (CHI-DO) |
Frequently Asked Questions
What is Dyna Drugs's FDA import refusal history?
Dyna Drugs (FEI: 3003388279) has 1 FDA import refusal record(s) in our database, spanning from 8/6/2010 to 8/6/2010.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Dyna Drugs's FEI number is 3003388279.
What types of violations has Dyna Drugs received?
Dyna Drugs has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Dyna Drugs come from?
All FDA import refusal data for Dyna Drugs is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.